Over the last 12 months, Scholar Rock Holding insiders reported 2 buys totaling $20.0M and 27 sales totaling $19.5M across SEC Form 4 filings. 38% of those filings were made under pre-arranged 10b5-1 trading plans.
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | FLIER JEFFREY S.D | ▼ Sale | 3,053 | $53.88 | $164K | -9.9% | plan · 3 tranches |
| Jul 1, 2026 | Gilman MichaelD | ▼ Sale | 2,544 | $53.87 | $137K | -4.1% | plan · 3 tranches |
| Jul 1, 2026 | Burow KristinaD | ▼ Sale | 3,053 | $53.74 | $164K | -2.6% | plan · 2 tranches |
| Jul 1, 2026 | Reed JoshuaD | ▼ Sale | 3,053 | $53.74 | $164K | -13.5% | plan · 2 tranches |
| Jul 1, 2026 | Peng KatieD | ▼ Sale | 5,446 | $53.88 | $293K | -13.7% | plan · 3 tranches |
| Apr 16, 2026 | Woods KeithChief Operating Officer · O | ▼ Sale | 10,220 | $49.57 | $507K | -1.6% | — |
| Apr 16, 2026 | Vaishnaw AkshayPresident of R&D · O·D | ▼ Sale | 12,246 | $49.57 | $607K | -1.9% | — |
| Apr 16, 2026 | Sinha VikasChief Financial Officer · O | ▼ Sale | 10,410 | $49.57 | $516K | -1.7% | — |
| Apr 16, 2026 | Hallal DavidChief Executive Officer · O·D | ▼ Sale | 30,615 | $49.57 | $1.5M | -1.8% | — |
| Feb 23, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER · O | ▼ Sale | 8,484 | $47.07 | $399K | -7.9% | plan · 3 tranches |
| Feb 17, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER · O | ▼ Sale | 7,989 | $46.53 | $372K | -7% | — |
| Feb 17, 2026 | Parlavecchio CarynCHRO · O | ▼ Sale | 9,035 | $46.53 | $420K | -5.1% | — |
| Feb 17, 2026 | Ho JunlinGENERAL COUNSEL · O | ▼ Sale | 9,580 | $46.53 | $446K | -3.8% | — |
| Feb 17, 2026 | Marantz Jing L.CHIEF MEDICAL OFFICER · O | ▼ Sale | 4,157 | $46.53 | $193K | -3.2% | — |
| Jan 22, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER · O | ▼ Sale | 14,898 | $46.71 | $696K | -14.8% | plan · 2 tranches |
| Jan 16, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER · O | ▼ Sale | 8,406 | $44.48 | $374K | -7.7% | — |
| Jan 16, 2026 | Parlavecchio CarynCHRO · O | ▼ Sale | 6,600 | $44.48 | $294K | -4.2% | — |
| Jan 16, 2026 | Ho JunlinGENERAL COUNSEL · O | ▼ Sale | 8,016 | $44.48 | $357K | -3.6% | — |
| Jan 16, 2026 | Marantz Jing L.CHIEF MEDICAL OFFICER · O | ▼ Sale | 5,798 | $44.48 | $258K | -5.7% | — |
| Jan 14, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER · O | ▼ Sale | 13,112 | $45.2 | $593K | -10.7% | plan |
| Jan 13, 2026 | Sinha VikasChief Financial Officer · O | ▼ Sale | 16,755 | $42.7 | $715K | -2.8% | — |
| Jan 13, 2026 | Woods KeithChief Operating Officer · O | ▼ Sale | 16,746 | $42.7 | $715K | -2.8% | — |
| Jan 13, 2026 | Vaishnaw AkshayPresident of R&D · O·D | ▼ Sale | 20,438 | $42.7 | $873K | -3.3% | — |
| Jan 13, 2026 | Hallal DavidChief Executive Officer · O·D | ▼ Sale | 57,450 | $42.7 | $2.5M | -3.6% | — |
| Dec 16, 2025 | Peng KatieD | ▼ Sale | 1,006 | $44.09 | $44K | -3% | plan · 2 tranches |
| Dec 4, 2025 | Qatanani MoCHIEF SCIENTIFIC OFFICER · O | ▼ Sale | 136,462 | $45.21 | $6.2M | -55.6% | plan |
| Oct 7, 2025 | AKKARAJU SRINIVASD | ▲ Buy | 29,599 | $39.92 | $1.2M | +5.9% | late · 3 tranches · indirect |
| Oct 6, 2025 | AKKARAJU SRINIVASD | ▲ Buy | 500,439 | $37.58 | $18.8M | — | 6 tranches · indirect |
| Sep 22, 2025 | Qatanani MoCHIEF SCIENTIFIC OFFICER · O | ▼ Sale | 3,353 | $30.67 | $103K | -3% | plan |
| Sep 16, 2025 | Peng KatieD | ▼ Sale | 1,006 | $32.53 | $33K | -2.9% | plan · 2 tranches |
| Sep 16, 2025 | Qatanani MoCHIEF SCIENTIFIC OFFICER · O | ▼ Sale | 3,178 | $33.52 | $107K | -2.8% | — |
| Aug 18, 2025 | Parlavecchio CarynCHRO · O | ▼ Sale | 2,178 | $31.17 | $68K | -1.4% | — |
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Scholar Rock Holding filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $SRRK feed.